(3S)- AND (3R)-6,7-BIS(HYDROXYMETHYL)-1H,3H-PYRROLO[1,2-C]THIAZOLES AS P53 ACTIVATORS

(3S)- AND (3R)-6,7-BIS(HYDROXYMETHYL)-1H,3H-PYRROLO[1,2-C]THIAZOLES AS P53 ACTIVATORS

The present application relates to compounds of formula I, which are (3S)- and (3R)-6,7-bis(Hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles. The present application also relates to pharmaceutical compositions having the compounds and the use of these compounds in the treatment of conditions influenced...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LOPES SOARES, Maria Isabel, NOGUEIRA RAMOS ROCHA, Helena Isabel, GAMA SOARES, Joana Oliveira, VASCONCELOS DIAS DE PINHO E MELO, Teresa, ATAÍDE SARAIVA, Lucília Helena
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LOPES SOARES, Maria Isabel
NOGUEIRA RAMOS ROCHA, Helena Isabel
GAMA SOARES, Joana Oliveira
VASCONCELOS DIAS DE PINHO E MELO, Teresa
ATAÍDE SARAIVA, Lucília Helena
description The present application relates to compounds of formula I, which are (3S)- and (3R)-6,7-bis(Hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles. The present application also relates to pharmaceutical compositions having the compounds and the use of these compounds in the treatment of conditions influenced by wild-type or mutant p53 forms. More specifically, these compounds represent a completely new chemical family of p53-activating agents and show a higher selectivity towards the p53-pathway compared to the reactivators of p53 currently under clinical trials. For some cancer types these compounds revealed to be more potent than the reactivators of p53 currently under clinical trials. In addition to these advantages, the presently disclosed compounds are not genotoxic and have no apparent undesirable toxic side effects.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3810278A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3810278A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3810278A13</originalsourceid><addsrcrecordid>eNrjZAjVMA7W1FVw9HNR0DAO0tQ10zHXdfIM1vCIdAnyj4j0dQ3xiPTR1DX00DH20A2IDAry9_GPNtQx0nWODfHwdIzy93ENVnAMVggwNVZwdA7xDHMM8Q8K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxhaGBkbmFo6GxkQoAQA0wi6-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>(3S)- AND (3R)-6,7-BIS(HYDROXYMETHYL)-1H,3H-PYRROLO[1,2-C]THIAZOLES AS P53 ACTIVATORS</title><source>esp@cenet</source><creator>LOPES SOARES, Maria Isabel ; NOGUEIRA RAMOS ROCHA, Helena Isabel ; GAMA SOARES, Joana Oliveira ; VASCONCELOS DIAS DE PINHO E MELO, Teresa ; ATAÍDE SARAIVA, Lucília Helena</creator><creatorcontrib>LOPES SOARES, Maria Isabel ; NOGUEIRA RAMOS ROCHA, Helena Isabel ; GAMA SOARES, Joana Oliveira ; VASCONCELOS DIAS DE PINHO E MELO, Teresa ; ATAÍDE SARAIVA, Lucília Helena</creatorcontrib><description>The present application relates to compounds of formula I, which are (3S)- and (3R)-6,7-bis(Hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles. The present application also relates to pharmaceutical compositions having the compounds and the use of these compounds in the treatment of conditions influenced by wild-type or mutant p53 forms. More specifically, these compounds represent a completely new chemical family of p53-activating agents and show a higher selectivity towards the p53-pathway compared to the reactivators of p53 currently under clinical trials. For some cancer types these compounds revealed to be more potent than the reactivators of p53 currently under clinical trials. In addition to these advantages, the presently disclosed compounds are not genotoxic and have no apparent undesirable toxic side effects.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210428&amp;DB=EPODOC&amp;CC=EP&amp;NR=3810278A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210428&amp;DB=EPODOC&amp;CC=EP&amp;NR=3810278A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LOPES SOARES, Maria Isabel</creatorcontrib><creatorcontrib>NOGUEIRA RAMOS ROCHA, Helena Isabel</creatorcontrib><creatorcontrib>GAMA SOARES, Joana Oliveira</creatorcontrib><creatorcontrib>VASCONCELOS DIAS DE PINHO E MELO, Teresa</creatorcontrib><creatorcontrib>ATAÍDE SARAIVA, Lucília Helena</creatorcontrib><title>(3S)- AND (3R)-6,7-BIS(HYDROXYMETHYL)-1H,3H-PYRROLO[1,2-C]THIAZOLES AS P53 ACTIVATORS</title><description>The present application relates to compounds of formula I, which are (3S)- and (3R)-6,7-bis(Hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles. The present application also relates to pharmaceutical compositions having the compounds and the use of these compounds in the treatment of conditions influenced by wild-type or mutant p53 forms. More specifically, these compounds represent a completely new chemical family of p53-activating agents and show a higher selectivity towards the p53-pathway compared to the reactivators of p53 currently under clinical trials. For some cancer types these compounds revealed to be more potent than the reactivators of p53 currently under clinical trials. In addition to these advantages, the presently disclosed compounds are not genotoxic and have no apparent undesirable toxic side effects.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAjVMA7W1FVw9HNR0DAO0tQ10zHXdfIM1vCIdAnyj4j0dQ3xiPTR1DX00DH20A2IDAry9_GPNtQx0nWODfHwdIzy93ENVnAMVggwNVZwdA7xDHMM8Q8K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxhaGBkbmFo6GxkQoAQA0wi6-</recordid><startdate>20210428</startdate><enddate>20210428</enddate><creator>LOPES SOARES, Maria Isabel</creator><creator>NOGUEIRA RAMOS ROCHA, Helena Isabel</creator><creator>GAMA SOARES, Joana Oliveira</creator><creator>VASCONCELOS DIAS DE PINHO E MELO, Teresa</creator><creator>ATAÍDE SARAIVA, Lucília Helena</creator><scope>EVB</scope></search><sort><creationdate>20210428</creationdate><title>(3S)- AND (3R)-6,7-BIS(HYDROXYMETHYL)-1H,3H-PYRROLO[1,2-C]THIAZOLES AS P53 ACTIVATORS</title><author>LOPES SOARES, Maria Isabel ; NOGUEIRA RAMOS ROCHA, Helena Isabel ; GAMA SOARES, Joana Oliveira ; VASCONCELOS DIAS DE PINHO E MELO, Teresa ; ATAÍDE SARAIVA, Lucília Helena</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3810278A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LOPES SOARES, Maria Isabel</creatorcontrib><creatorcontrib>NOGUEIRA RAMOS ROCHA, Helena Isabel</creatorcontrib><creatorcontrib>GAMA SOARES, Joana Oliveira</creatorcontrib><creatorcontrib>VASCONCELOS DIAS DE PINHO E MELO, Teresa</creatorcontrib><creatorcontrib>ATAÍDE SARAIVA, Lucília Helena</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LOPES SOARES, Maria Isabel</au><au>NOGUEIRA RAMOS ROCHA, Helena Isabel</au><au>GAMA SOARES, Joana Oliveira</au><au>VASCONCELOS DIAS DE PINHO E MELO, Teresa</au><au>ATAÍDE SARAIVA, Lucília Helena</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>(3S)- AND (3R)-6,7-BIS(HYDROXYMETHYL)-1H,3H-PYRROLO[1,2-C]THIAZOLES AS P53 ACTIVATORS</title><date>2021-04-28</date><risdate>2021</risdate><abstract>The present application relates to compounds of formula I, which are (3S)- and (3R)-6,7-bis(Hydroxymethyl)-1H,3H-pyrrolo[1,2-c]thiazoles. The present application also relates to pharmaceutical compositions having the compounds and the use of these compounds in the treatment of conditions influenced by wild-type or mutant p53 forms. More specifically, these compounds represent a completely new chemical family of p53-activating agents and show a higher selectivity towards the p53-pathway compared to the reactivators of p53 currently under clinical trials. For some cancer types these compounds revealed to be more potent than the reactivators of p53 currently under clinical trials. In addition to these advantages, the presently disclosed compounds are not genotoxic and have no apparent undesirable toxic side effects.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3810278A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title (3S)- AND (3R)-6,7-BIS(HYDROXYMETHYL)-1H,3H-PYRROLO[1,2-C]THIAZOLES AS P53 ACTIVATORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T18%3A53%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LOPES%20SOARES,%20Maria%20Isabel&rft.date=2021-04-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3810278A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true